{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:02:00Z","timestamp":1771063320338,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004761","name":"the Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2020JJ5871"],"award-info":[{"award-number":["2020JJ5871"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002238"],"award-info":[{"award-number":["82002238"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AMB Expr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Methicillin-resistant <jats:italic>Staphylococcus aureus<\/jats:italic> (MRSA) infection poses a severe threat to global public health due to its high mortality. Currently, polymyxins are mainly used for the treatment of Gram-negative bacterial-related infection, while exhibiting limited antibacterial activities against <jats:italic>Staphylococcus aureus<\/jats:italic> (<jats:italic>S. aureus<\/jats:italic>). However, the combination of antibiotics with antibiotic adjuvants is a feasible strategy for the hard-treated infection and toxicity reducing. We will investigate the antibacterial activity of simeprevir (SIM), which treated for genotype 1 and 4 chronic hepatitis C, combined with polymyxins against MRSA through high-throughput screening technology. In our study, the synergistic antibacterial effect of SIM and polymyxins against <jats:italic>S. aureus<\/jats:italic> in vitro was found by checkerboard assay and time-growth curve. The cytotoxicity of SIM combined with polymyxin B sulfate [PB(S)] or polymyxin E (PE) in vitro was evaluated using CCK-8, human RBC hemolysis and scratch assays. In addition, we investigated the eradication of biofilm formation of <jats:italic>S. aureus<\/jats:italic> by biofilm inhibition assay and the killing of persister cells. Moreover, we evaluated the therapeutic effect and in vivo toxicity of the combination against MRSA in murine subcutaneous abscess model. Furthermore, it was preliminarily found that SIM significantly enhanced the destruction of MRSA membrane by SYTOX Green and DISC3(5) probes. In summary, these results reveal that the therapy of SIM combined with polymyxins (especially PE) is promising for the treatment of MRSA infection.<\/jats:p>","DOI":"10.1186\/s13568-023-01634-8","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T16:02:04Z","timestamp":1698940924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Simeprevir restores the anti-Staphylococcus activity of polymyxins"],"prefix":"10.1186","volume":"13","author":[{"given":"Yuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingyun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruolan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huilong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoni","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"She","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"1634_CR1","doi-asserted-by":"publisher","unstructured":"Ayoub Moubareck C (2020) Polymyxins and bacterial membranes: a review of antibacterial activity and mechanisms of resistance. Membr (Basel) 10(8). https:\/\/doi.org\/10.3390\/membranes10080181","DOI":"10.3390\/membranes10080181"},{"key":"1634_CR2","doi-asserted-by":"publisher","first-page":"114171","DOI":"10.1016\/j.addr.2022.114171","volume":"183","author":"X Bian","year":"2022","unstructured":"Bian X, Qu X, Zhang J, Nang SC, Bergen PJ, Tony Zhou Q, Chan HK, Feng M, Li J (2022) Pharmacokinetics and pharmacodynamics of peptide antibiotics. Adv Drug Deliv Rev 183:114171. https:\/\/doi.org\/10.1016\/j.addr.2022.114171","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"1634_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1021\/bi9512408","volume":"35","author":"Y Cajal","year":"1996","unstructured":"Cajal Y, Rogers J, Berg OG, Jain MK (1996) Intermembrane molecular contacts by polymyxin B mediate exchange of phospholipids. Biochemistry 35(1):299\u2013308. https:\/\/doi.org\/10.1021\/bi9512408","journal-title":"Biochemistry"},{"issue":"1","key":"1634_CR4","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1080\/21505594.2018.1460187","volume":"9","author":"M Carretero-Ledesma","year":"2018","unstructured":"Carretero-Ledesma M, Garc\u00eda-Quintanilla M, Mart\u00edn-Pe\u00f1a R, Pulido MR, Pach\u00f3n J, McConnell MJ (2018) Phenotypic changes associated with colistin resistance due to lipopolysaccharide loss in Acinetobacter baumannii. Virulence 9(1):930\u2013942. https:\/\/doi.org\/10.1080\/21505594.2018.1460187","journal-title":"Virulence"},{"key":"1634_CR5","unstructured":"CLSI (2023) M100 Performance standards for antimicrobial susceptibility testing, 33rd Edition"},{"key":"1634_CR6","doi-asserted-by":"publisher","unstructured":"Dai C, Wang Y, Sharma G, Shen J, Velkov T, Xiao X (2020) Polymyxins-curcumin combination antimicrobial therapy: Safety implications and efficacy for Infection treatment. Antioxid (Basel) 9(6). https:\/\/doi.org\/10.3390\/antiox9060506","DOI":"10.3390\/antiox9060506"},{"key":"1634_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/82_2017_42","volume":"409","author":"MZ David","year":"2017","unstructured":"David MZ, Daum RS (2017) Treatment of Staphylococcus aureus Infections. Curr Top Microbiol Immunol 409:325\u2013383. https:\/\/doi.org\/10.1007\/82_2017_42","journal-title":"Curr Top Microbiol Immunol"},{"key":"1634_CR8","doi-asserted-by":"publisher","unstructured":"De Oliveira DMP, Keller B, Hayes AJ, Ong CY, Harbison-Price N, El-Deeb IM, Li G, Keller N, Bohlmann L, Brouwer S, Turner AG, Cork AJ, Jones TR, Paterson DL, McEwan AG, Davies MR, McDevitt CA, Itzstein MV, Walker MJ (2022) Neurodegenerative Disease Treatment Drug PBT2 breaks intrinsic Polymyxin Resistance in Gram-positive Bacteria. Antibiot (Basel) 11(4). https:\/\/doi.org\/10.3390\/antibiotics11040449","DOI":"10.3390\/antibiotics11040449"},{"key":"1634_CR9","doi-asserted-by":"publisher","unstructured":"Diekema DJ, Hsueh PR, Mendes RE, Pfaller MA, Rolston KV, Sader HS, Jones RN (2019) The microbiology of bloodstream Infection: 20-year trends from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother 63(7). https:\/\/doi.org\/10.1128\/aac.00355-19","DOI":"10.1128\/aac.00355-19"},{"issue":"19","key":"1634_CR10","doi-asserted-by":"publisher","first-page":"8665","DOI":"10.1021\/acs.jmedchem.8b01781","volume":"62","author":"H Douafer","year":"2019","unstructured":"Douafer H, Andrieu V, Phanstiel Ot, Brunel JM (2019) Antibiotic adjuvants: make antibiotics great again! J Med Chem 62(19):8665\u20138681. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01781","journal-title":"J Med Chem"},{"key":"1634_CR11","doi-asserted-by":"publisher","first-page":"624775","DOI":"10.3389\/fimmu.2021.624775","volume":"12","author":"F Fan","year":"2021","unstructured":"Fan F, Ma Y, Ai R, Ding Z, Li D, Zhu Y, He Q, Zhang X, Dong Y, He Y (2021) Glycolytic metabolism iIs critical for the innate antibacterial defense in acute Streptococcus pneumoniae otitis media. Front Immunol 12:624775. https:\/\/doi.org\/10.3389\/fimmu.2021.624775","journal-title":"Front Immunol"},{"issue":"8","key":"1634_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrmicro.2017.42","volume":"15","author":"RA Fisher","year":"2017","unstructured":"Fisher RA, Gollan B, Helaine S (2017) Persistent bacterial Infections and persister cells. Nat Rev Microbiol 15(8):453\u2013464. https:\/\/doi.org\/10.1038\/nrmicro.2017.42","journal-title":"Nat Rev Microbiol"},{"issue":"10","key":"1634_CR13","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.4049\/jimmunol.1302692","volume":"192","author":"MC Greenlee-Wacker","year":"2014","unstructured":"Greenlee-Wacker MC, Rigby KM, Kobayashi SD, Porter AR, DeLeo FR, Nauseef WM (2014) Phagocytosis of Staphylococcus aureus by human neutrophils prevents macrophage efferocytosis and induces programmed necrosis. J Immunol 192(10):4709\u20134717. https:\/\/doi.org\/10.4049\/jimmunol.1302692","journal-title":"J Immunol"},{"issue":"1","key":"1634_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.idc.2020.10.003","volume":"35","author":"TJ Hatlen","year":"2021","unstructured":"Hatlen TJ, Miller LG (2021) Staphylococcal skin and soft tissue Infections. Infect Dis Clin North Am 35(1):81\u2013105. https:\/\/doi.org\/10.1016\/j.idc.2020.10.003","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"1634_CR15","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/jac\/dkz053","volume":"74","author":"J Kang","year":"2019","unstructured":"Kang J, Dietz MJ, Hughes K, Xing M, Li B (2019) Silver nanoparticles present high intracellular and extracellular killing against Staphylococcus aureus. J Antimicrob Chemother 74(6):1578\u20131585. https:\/\/doi.org\/10.1093\/jac\/dkz053","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"1634_CR16","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.cell.2007.06.049","volume":"130","author":"MA Kohanski","year":"2007","unstructured":"Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ (2007) A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130(5):797\u2013810. https:\/\/doi.org\/10.1016\/j.cell.2007.06.049","journal-title":"Cell"},{"key":"1634_CR17","doi-asserted-by":"publisher","unstructured":"Lakhundi S, Zhang K (2018) Methicillin-resistant Staphylococcus aureus: molecular characterization, evolution, and epidemiology. Clin Microbiol Rev 31(4). https:\/\/doi.org\/10.1128\/cmr.00020-18","DOI":"10.1128\/cmr.00020-18"},{"key":"1634_CR18","doi-asserted-by":"publisher","first-page":"18033","DOI":"10.1038\/nrdp.2018.33","volume":"4","author":"AS Lee","year":"2018","unstructured":"Lee AS, de Lencastre H, Garau J, Kluytmans J, Malhotra-Kumar S, Peschel A, Harbarth S (2018) Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers 4:18033. https:\/\/doi.org\/10.1038\/nrdp.2018.33","journal-title":"Nat Rev Dis Primers"},{"key":"1634_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-3-030-16373-0_4","volume":"1145","author":"Z Li","year":"2019","unstructured":"Li Z, Velkov T (2019) Polymyxins: Mode of action. Adv Exp Med Biol 1145:37\u201354. https:\/\/doi.org\/10.1007\/978-3-030-16373-0_4","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"1634_CR19","doi-asserted-by":"publisher","first-page":"2001750","DOI":"10.1002\/advs.202001750","volume":"8","author":"Y Li","year":"2021","unstructured":"Li Y, Liu F, Zhang J, Liu X, Xiao P, Bai H, Chen S, Wang D, Sung SHP, Kwok RTK, Shen J, Zhu K, Tang BZ (2021) Efficient killing of multidrug-resistant internalized bacteria by AIEgens in vivo. Adv Sci (Weinh) 8(9):2001750. https:\/\/doi.org\/10.1002\/advs.202001750","journal-title":"Adv Sci (Weinh)"},{"issue":"7","key":"1634_CR20","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1007\/s00253-022-11878-2","volume":"106","author":"Y Li","year":"2022","unstructured":"Li Y, She P, Xu L, Liu Y, Liu S, Li Z, Yang Y, Li L, Hussain Z, Wu Y (2022) Anti-hepatitis C virus drug simeprevir: a promising antimicrobial agent against MRSA. Appl Microbiol Biotechnol 106(7):2689\u20132702. https:\/\/doi.org\/10.1007\/s00253-022-11878-2","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"1634_CR22","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3892\/or.2018.6576","volume":"40","author":"Z Lin","year":"2018","unstructured":"Lin Z, Liu W, Xiao C, Fan Y, Zhuang G, Qi Z (2018) TIPE2 inhibits GC via regulation of cell proliferation, apoptosis and inflammation. Oncol Rep 40(3):1307\u20131316. https:\/\/doi.org\/10.3892\/or.2018.6576","journal-title":"Oncol Rep"},{"issue":"2","key":"1634_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/cmi.2016.60","volume":"15","author":"Y Liu","year":"2018","unstructured":"Liu Y, Pan YF, Xue YQ, Fang LK, Guo XH, Guo X, Liu M, Mo BY, Yang MR, Liu F, Wu YT, Olsen N, Zheng SG (2018) uPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K\/Akt signaling pathway in patients with rheumatoid arthritis. Cell Mol Immunol 15(2):171\u2013181. https:\/\/doi.org\/10.1038\/cmi.2016.60","journal-title":"Cell Mol Immunol"},{"key":"1634_CR24","doi-asserted-by":"publisher","first-page":"727692","DOI":"10.3389\/fmicb.2021.727692","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, She P, Xu L, Chen L, Li Y, Liu S, Li Z, Hussain Z, Wu Y (2021) Antimicrobial, antibiofilm, and anti-persister activities of penfluridol against Staphylococcus aureus. Front Microbiol 12:727692. https:\/\/doi.org\/10.3389\/fmicb.2021.727692","journal-title":"Front Microbiol"},{"issue":"8","key":"1634_CR25","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1056\/nejm199808203390806","volume":"339","author":"FD Lowy","year":"1998","unstructured":"Lowy FD (1998) Staphylococcus aureus Infections. N Engl J Med 339(8):520\u2013532. https:\/\/doi.org\/10.1056\/nejm199808203390806","journal-title":"N Engl J Med"},{"issue":"11","key":"1634_CR26","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.4252\/wjsc.v13.i11.1762","volume":"13","author":"ZW Luo","year":"2021","unstructured":"Luo ZW, Sun YY, Lin JR, Qi BJ, Chen JW (2021) Exosomes derived from inflammatory myoblasts promote M1 polarization and break the balance of myoblast proliferation\/differentiation. World J Stem Cells 13(11):1762\u20131782. https:\/\/doi.org\/10.4252\/wjsc.v13.i11.1762","journal-title":"World J Stem Cells"},{"issue":"7","key":"1634_CR27","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3851\/imp1894","volume":"16","author":"M Manns","year":"2011","unstructured":"Manns M, Reesink H, Berg T, Dusheiko G, Flisiak R, Marcellin P, Moreno C, Lenz O, Meyvisch P, Peeters M, Sekar V, Simmen K, Verloes R (2011) Rapid viral response of once-daily TMC435 plus pegylated interferon\/ribavirin in Hepatitis C genotype-1 patients: a randomized trial. Antivir Ther 16(7):1021\u20131033. https:\/\/doi.org\/10.3851\/imp1894","journal-title":"Antivir Ther"},{"key":"1634_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-3-030-16373-0_5","volume":"1145","author":"JH Moffatt","year":"2019","unstructured":"Moffatt JH, Harper M, Boyce JD (2019) Mechanisms of polymyxin resistance. Adv Exp Med Biol 1145:55\u201371. https:\/\/doi.org\/10.1007\/978-3-030-16373-0_5","journal-title":"Adv Exp Med Biol"},{"key":"1634_CR29","doi-asserted-by":"publisher","unstructured":"Mohapatra SS, Dwibedy SK, Padhy I (2021) Polymyxins, the last-resort antibiotics: Mode of action, resistance emergence, and potential solutions. J Biosci 46(3). https:\/\/doi.org\/10.1007\/s12038-021-00209-8","DOI":"10.1007\/s12038-021-00209-8"},{"issue":"2","key":"1634_CR30","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1124\/pharmrev.120.000020","volume":"73","author":"SC Nang","year":"2021","unstructured":"Nang SC, Azad MAK, Velkov T, Zhou QT, Li J (2021) Rescuing the last-line polymyxins: achievements and challenges. Pharmacol Rev 73(2):679\u2013728. https:\/\/doi.org\/10.1124\/pharmrev.120.000020","journal-title":"Pharmacol Rev"},{"issue":"5","key":"1634_CR31","doi-asserted-by":"publisher","first-page":"664","DOI":"10.2174\/1389201022666210708171123","volume":"23","author":"A Nasser","year":"2022","unstructured":"Nasser A, Dallal MMS, Jahanbakhshi S, Azimi T, Nikouei L (2022) Staphylococcus aureus: Biofilm formation and strategies against it. Curr Pharm Biotechnol 23(5):664\u2013678. https:\/\/doi.org\/10.2174\/1389201022666210708171123","journal-title":"Curr Pharm Biotechnol"},{"issue":"1","key":"1634_CR32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/cid\/ciu213","volume":"59","author":"RL Nation","year":"2014","unstructured":"Nation RL, Velkov T, Li J (2014) Colistin and polymyxin B: peas in a pod, or chalk and cheese? Clin Infect Dis 59(1):88\u201394. https:\/\/doi.org\/10.1093\/cid\/ciu213","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1634_CR33","doi-asserted-by":"publisher","first-page":"e1007084","DOI":"10.1371\/journal.ppat.1007084","volume":"14","author":"D Pletzer","year":"2018","unstructured":"Pletzer D, Mansour SC, Hancock REW (2018) Synergy between conventional antibiotics and anti-biofilm peptides in a murine, sub-cutaneous abscess model caused by recalcitrant ESKAPE pathogens. PLoS Pathog 14(6):e1007084. https:\/\/doi.org\/10.1371\/journal.ppat.1007084","journal-title":"PLoS Pathog"},{"key":"1634_CR34","doi-asserted-by":"publisher","unstructured":"Rowe SE, Beam JE, Conlon BP (2021) Recalcitrant Staphylococcus aureus Infections: obstacles and solutions. Infect Immun 89(4). https:\/\/doi.org\/10.1128\/iai.00694-20","DOI":"10.1128\/iai.00694-20"},{"issue":"12","key":"1634_CR35","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1093\/jac\/dky366","volume":"73","author":"H Rudilla","year":"2018","unstructured":"Rudilla H, P\u00e9rez-Guill\u00e9n I, Rabanal F, Sierra JM, Vinuesa T, Vi\u00f1as M (2018) Novel synthetic polymyxins kill Gram-positive bacteria. J Antimicrob Chemother 73(12):3385\u20133390. https:\/\/doi.org\/10.1093\/jac\/dky366","journal-title":"J Antimicrob Chemother"},{"key":"1634_CR36","doi-asserted-by":"publisher","unstructured":"Sabnis A, Hagart KL, Kl\u00f6ckner A, Becce M, Evans LE, Furniss RCD, Mavridou DA, Murphy R, Stevens MM, Davies JC, Larrouy-Maumus GJ, Clarke TB, Edwards AM (2021) Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane. Elife 10. https:\/\/doi.org\/10.7554\/eLife.65836","DOI":"10.7554\/eLife.65836"},{"key":"1634_CR37","doi-asserted-by":"publisher","unstructured":"Schilcher K, Horswill AR (2020) Staphylococcal biofilm development: structure, regulation, and treatment strategies. Microbiol Mol Biol Rev 84(3). https:\/\/doi.org\/10.1128\/mmbr.00026-19","DOI":"10.1128\/mmbr.00026-19"},{"key":"1634_CR38","doi-asserted-by":"publisher","first-page":"790686","DOI":"10.3389\/fmicb.2021.790686","volume":"12","author":"P She","year":"2021","unstructured":"She P, Li S, Zhou L, Liu Y, Xu L, Hussain Z, Li Y, Li Z, Liu S, Wu Y (2021) Repurposing eltrombopag as an antimicrobial agent against methicillin-resistant Staphylococcus aureus. Front Microbiol 12:790686. https:\/\/doi.org\/10.3389\/fmicb.2021.790686","journal-title":"Front Microbiol"},{"issue":"6","key":"1634_CR39","doi-asserted-by":"publisher","first-page":"e0211422","DOI":"10.1128\/spectrum.02114-22","volume":"10","author":"P She","year":"2022","unstructured":"She P, Li Z, Li Y, Liu S, Li L, Yang Y, Zhou L, Wu Y (2022) Pixantrone sensitizes Gram-negative pathogens to rifampin. Microbiol Spectr 10(6):e0211422. https:\/\/doi.org\/10.1128\/spectrum.02114-22","journal-title":"Microbiol Spectr"},{"issue":"2","key":"1634_CR40","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1021\/acsami.9b19927","volume":"12","author":"P Tan","year":"2020","unstructured":"Tan P, Lai Z, Jian Q, Shao C, Zhu Y, Li G, Shan A (2020) Design of heptad repeat amphiphiles based on database filtering and structure-function relationships to combat drug-resistant fungi and biofilms. ACS Appl Mater Interfaces 12(2):2129\u20132144. https:\/\/doi.org\/10.1021\/acsami.9b19927","journal-title":"ACS Appl Mater Interfaces"},{"issue":"5","key":"1634_CR41","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.ijantimicag.2019.03.009","volume":"53","author":"VM Thomas","year":"2019","unstructured":"Thomas VM, Brown RM, Ashcraft DS, Pankey GA (2019) Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii. Int J Antimicrob Agents 53(5):663\u2013668. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.03.009","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"1634_CR42","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/cmr.00134-14","volume":"28","author":"SY Tong","year":"2015","unstructured":"Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr (2015) Staphylococcus aureus Infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 28(3):603\u2013661. https:\/\/doi.org\/10.1128\/cmr.00134-14","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"1634_CR43","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.ijantimicag.2016.09.010","volume":"48","author":"TB Tran","year":"2016","unstructured":"Tran TB, Velkov T, Nation RL, Forrest A, Tsuji BT, Bergen PJ, Li J (2016) Pharmacokinetics\/pharmacodynamics of colistin and polymyxin B: are we there yet? Int J Antimicrob Agents 48(6):592\u2013597. https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.09.010","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"1634_CR44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-018-0141-x","volume":"17","author":"M Tyers","year":"2019","unstructured":"Tyers M, Wright GD (2019) Drug combinations: a strategy to extend the life of antibiotics in the 21st century. Nat Rev Microbiol 17(3):141\u2013155. https:\/\/doi.org\/10.1038\/s41579-018-0141-x","journal-title":"Nat Rev Microbiol"},{"key":"1634_CR45","doi-asserted-by":"publisher","first-page":"1048531","DOI":"10.3389\/fvets.2022.1048531","volume":"9","author":"S Ul Haq","year":"2022","unstructured":"Ul Haq S, Wang L, Guo W, Aqib AI, Muneer A, Saqib M, Ahmad S, Ghafoor M, Iftikhar A, Chen K, Liang J (2022) Enhancing activity of \u03b2-lactam and fluoroquinolones antibiotics by artemisinin and its derivatives against MDR Escherichia coli. Front Vet Sci 9:1048531. https:\/\/doi.org\/10.3389\/fvets.2022.1048531","journal-title":"Front Vet Sci"},{"issue":"18","key":"1634_CR46","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1007\/s40265-013-0153-9","volume":"73","author":"A Vaidya","year":"2013","unstructured":"Vaidya A, Perry CM (2013) Simeprevir: first global approval. Drugs 73(18):2093\u20132106. https:\/\/doi.org\/10.1007\/s40265-013-0153-9","journal-title":"Drugs"},{"key":"1634_CR47","doi-asserted-by":"publisher","unstructured":"V\u00e1zquez-S\u00e1nchez DA, Grillo S, Carrera-Salinas A, Gonz\u00e1lez-D\u00edaz A, Cuervo G, Grau I, Camoez M, Mart\u00ed S, Berbel D, Tubau F, Ardanuy C, Pujol M, C\u00e0mara J, Dom\u00ednguez M (2022) Molecular epidemiology, antimicrobial susceptibility, and clinical features of methicillin-resistant Staphylococcus aureus bloodstream Infections over 30 years in Barcelona, Spain (1990\u20132019). Microorganisms 10(12). https:\/\/doi.org\/10.3390\/microorganisms10122401","DOI":"10.3390\/microorganisms10122401"},{"issue":"3","key":"1634_CR48","doi-asserted-by":"publisher","first-page":"e0093722","DOI":"10.1128\/spectrum.00937-22","volume":"10","author":"M Xie","year":"2022","unstructured":"Xie M, Chen K, Chan EW, Chen S (2022) Synergistic antimicrobial effect of colistin in combination with econazole against multidrug-resistant Acinetobacter baumannii and its persisters. Microbiol Spectr 10(3):e0093722. https:\/\/doi.org\/10.1128\/spectrum.00937-22","journal-title":"Microbiol Spectr"},{"issue":"1","key":"1634_CR49","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s42003-022-03561-z","volume":"5","author":"C Xu","year":"2022","unstructured":"Xu C, Liu C, Chen K, Zeng P, Chan EWC, Chen S (2022) Otilonium bromide boosts antimicrobial activities of colistin against Gram-negative pathogens and their persisters. Commun Biol 5(1):613. https:\/\/doi.org\/10.1038\/s42003-022-03561-z","journal-title":"Commun Biol"},{"issue":"9","key":"1634_CR50","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1007\/s00253-020-10525-y","volume":"104","author":"J Yin","year":"2020","unstructured":"Yin J, Meng Q, Cheng D, Fu J, Luo Q, Liu Y, Yu Z (2020) Mechanisms of bactericidal action and resistance of polymyxins for Gram-positive bacteria. Appl Microbiol Biotechnol 104(9):3771\u20133780. https:\/\/doi.org\/10.1007\/s00253-020-10525-y","journal-title":"Appl Microbiol Biotechnol"},{"issue":"18","key":"1634_CR51","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1517\/14656566.2013.850074","volume":"14","author":"DM You","year":"2013","unstructured":"You DM, Pockros PJ (2013) Simeprevir for the treatment of chronic Hepatitis C. Expert Opin Pharmacother 14(18):2581\u20132589. https:\/\/doi.org\/10.1517\/14656566.2013.850074","journal-title":"Expert Opin Pharmacother"},{"key":"1634_CR52","doi-asserted-by":"publisher","unstructured":"Yu Z, Qin W, Lin J, Fang S, Qiu J (2015) Antibacterial mechanisms of polymyxin and bacterial resistance. Biomed Res Int 2015:679109. https:\/\/doi.org\/10.1155\/2015\/679109","DOI":"10.1155\/2015\/679109"},{"issue":"13","key":"1634_CR53","doi-asserted-by":"publisher","first-page":"2100681","DOI":"10.1002\/advs.202100681","volume":"8","author":"S Zhang","year":"2021","unstructured":"Zhang S, Qu X, Tang H, Wang Y, Yang H, Yuan W, Yue B (2021) Diclofenac Resensitizes Methicillin-resistant Staphylococcus aureus to \u03b2-Lactams and prevents Implant Infections. Adv Sci (Weinh) 8(13):2100681. https:\/\/doi.org\/10.1002\/advs.202100681","journal-title":"Adv Sci (Weinh)"}],"container-title":["AMB Express"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-023-01634-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13568-023-01634-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-023-01634-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T16:06:33Z","timestamp":1698941193000},"score":1,"resource":{"primary":{"URL":"https:\/\/amb-express.springeropen.com\/articles\/10.1186\/s13568-023-01634-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1634"],"URL":"https:\/\/doi.org\/10.1186\/s13568-023-01634-8","relation":{},"ISSN":["2191-0855"],"issn-type":[{"value":"2191-0855","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"3 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants performed by any of the authors. The animal study was approved after review by the Ethics Committee of the Third Xiangya Hospital, Central South University (NO: CSU-2022-0599).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"122"}}